PTEN and prostate adenocarcinoma: Moreover, it was reported that 25 of 42 (59%) of both the neoplastic prostate glands and the invasive prostatic adenocarcinomas cells in the lymph node showed complete lack of PTEN expression, and of these 52% exhibited already loss of PTEN expression at first diagnosis.